Eli Lilly

Schrodinger

Revvity

Eli Lilly Collaborates with Schrödinger and Revvity for AI-Driven Drug Discovery

Revvity and Lilly Collaborate on AI Drug Discovery Models Expansion

珀金埃尔默

Revvity's 15min chart triggers MACD Death Cross, KDJ Death Cross signal.

Revvity's 15-min chart: RSI overbought, KDJ death cross signals potential sell.

Revvity's 15min chart signals bullish momentum with KDJ Golden Cross and Bullish Marubozu.

Catalyst<ul> <li>Recent WR Oversold signals indicate a bullish bias for RVTY.</li></ul>Risk<ul> <li>Bearish signals are dominant in technical analysis with three bearish versus one bullish indicator.</li> <li>Recent technical signals are scarce and the market remains in a weak state with a risk of decline.</li> <li>Fund flow analysis shows net outflows across all size buckets indicating weak investor demand.</li> <li>Analyst ratings show inconsistency with two Neutral and one Buy ratings reflecting mixed institutional views.</li></ul>

Key Factors

Revvity collaborated with Eli Lilly to expand access to Lilly's AI drug discovery models via Revvity's Signals Xynthetica platform.

Recent Updates

RVTY News